Measure ID: MIPS 465|Interventional Radiology|2026 Performance Year

Uterine Artery Embolization Technique: Documentation of Angiographic Endpoints

The percentage of patients with documentation of angiographic endpoints of embolization AND the documentation of embolization strategies in the presence of unilateral or bilateral absent uterine arteries.

Process – High PriorityInterventional RadiologyAppropriate Treatment

Last updated: January 15, 2026

⚙️

Measure Specification

Denominator (Eligible Population)

All patients, regardless of age
ANDDiagnosis for leiomyomas or adenomyosis
ANDPatient procedure during the performance period
ORPerformance Not Met: Embolization endpoints are not documented separately for each embolized vessel OR ovarian artery angiography or embolization not performed in the presence of variant uterine artery anatomy (G9963)

Denominator Exclusions

None

Numerator

Number of patients undergoing uterine artery embolization for symptomatic leiomyomas and/or adenomyosis in whom embolization endpoints are documented separately for each embolized vessel AND ovarian artery angiography or embolization performed in the presence of variant uterine artery anatomy.

Submission Codes (QDCs)

✓ Performance Met
G9962Embolization endpoints are documented separately for each embolized vessel AND ovarian artery angiography or embolization performed in the presence of variant uterine artery anatomy
✗ Performance Not Met
G9963Embolization endpoints are not documented separately for each embolized vessel OR ovarian artery angiography or embolization not performed in the presence of variant uterine artery anatomy

Denominator Exceptions

None — this measure has no denominator exceptions.

🧮MIPS Score Simulator

Estimate only — actual CMS scoring may vary based on reporting method, data completeness, and annual rule updates.

%Benchmarks vary by collection type
💡 Tip: Enter your performance rate to compare MIPS points across all collection types. The same rate can score differently depending on how you submit.
VBCA Insights

💡Why This Measure Matters

Uterine artery embolization treats symptomatic fibroids and adenomyosis by blocking blood flow to abnormal tissue, but success depends on achieving complete embolization and identifying all feeding vessels. This measure ensures you document the embolization endpoint for each vessel and that you've assessed for variant arterial anatomy (like absent uterine arteries). Careful documentation reflects procedural quality and helps identify when ovarian arteries need treatment to prevent recurrence.

📖Clinical Rationale

The efficacy of uterine artery embolization is related to incomplete embolization. The two failure mechanisms that contribute are (1.) appropriate vessel selection but insufficient embolization and (2.) incomplete identification of uterine arterial supply. This measure ensures documentation of two important procedural aspects of uterine artery embolization, which are known to be associated with treatment efficacy: (1.

) appropriate embolization endpoints achieved and (2.) delineation of all uterine arterial supply with embolization where possible. Inadequate arterial embolization alone is a known cause of treatment failure. 1 The ovarian arteries often provide an alternate route of arterial supply to the uterus when the uterine artery is occluded or absent; however routine aortography is not recommended when conventional uterine artery anatomy is present.

📝Clinical Recommendations

Consensus opinion quality improvement document from the Society of Interventional Radiology utilizing the Modified Delphi method, defining consensus as 80% Delphi participant agreement on a value or parameter.1

📋Implementation Notes

This measure contains one strata defined by a single submission criteria. This measure produces a single performance rate. For the purposes of MIPS implementation, this procedure measure is submitted each time a procedure is performed during the performance period.

Report this measure through VBCA

Our QCDR handles measure selection, data validation, and submission—so you can focus on clinical performance.

Learn About Our QCDR →
© 2025 Society of Interventional Radiology.